HHG & Company’s Novartis NVS Stock Holding History

HHG & Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.38M	Buy	36,608 +1,362	+4%	+$92.7K	0.66%	51
2015 Q4	$2.72M	Buy	35,246 +321	+0.9%	+$25.5K	0.73%	35
2015 Q3	$2.88M	Buy	34,925 +8	+0%	+$712	0.87%	26
2015 Q2	$3.08M	Buy	34,917 +1,816	+5%	+$167K	0.89%	28
2015 Q1	$2.92M	Buy	33,101 +135	+0.4%	+$12K	0.77%	33
2014 Q4	$2.74M	Buy	32,966 +3,542	+12%	+$294K	0.65%	38
2014 Q3	$2.48M	Buy	29,424 +2,169	+8%	+$175K	0.81%	28
2014 Q2	$2.21M	Buy	27,255 +1,658	+6%	+$130K	0.72%	47
2014 Q1	$1.95M	Buy	25,597 +2,357	+10%	+$172K	0.67%	49
2013 Q4	$1.67M	Buy	23,240 +438	+2%	+$30.4K	0.62%	55
2013 Q3	$1.57M	Buy	22,802 +730	+3%	+$48.3K	0.63%	52
2013 Q2	$1.4M	Buy	+22,072	New	+$1.44M	0.56%	56

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return

HHG & Company's NVS Position: Q1 2016 in Review

HHG & Company increased its Novartis (NVS) stake by 3.9% in Q1 2016, buying an estimated $92.7K and bringing the position to 36,608 shares worth $2.38M. The position accounts for 0.66% of the portfolio, ranked #51.

HHG & Company first reported a position in NVS in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.08M in Q2 2015. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

HHG & Company held 36,608 shares of Novartis worth $2.38M as of Q1 2016.
HHG & Company bought 1,362 Novartis shares in Q1 2016, an estimated $92.7K.
Novartis made up 0.66% of HHG & Company's portfolio in Q1 2016, its #51 holding.
HHG & Company first reported a position in Novartis in Q2 2013 and has held it in 12 quarters since.
HHG & Company's Novartis position peaked at $3.08M in Q2 2015.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on HHG & Company's 13F filing for Q1 2016, filed 20 Apr 2016.